0

The Translational Genomics Research Institute – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Publisher Name :
Date: 17-May-2017
No. of pages: 35

Summary

The Translational Genomics Research Institute (TGen), formerly known as Arizona Bioscience and Bio-medicine Institute, is a non-profit organization that focuses on developing earlier diagnostics and treatments. The organization conducts clinical trials to investigate new chemical agents for the treatment of pancreatic cancer, breast cancer, leukemia, prostate cancer, lung cancer, and melanoma and incorporate novel tools for identifying patients’ genomic characteristics for a more targeted approach. TGen employs advances from the human genome project to develop prognostics, diagnostics, and therapies for treatment of neurological disorders, cancer, diabetes and other complex diseases. The organization also conducts research programs for finding new therapies for the treatment of autism, breast cancer, diabetes, gastric cancer, melanoma, and prostate cancer. It operates through its research units. TGen is headquartered in Phoenix, Arizona, the US.

The Translational Genomics Research Institute – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

– Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
– Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
– Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
– Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
– Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
– Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
– Business Description – A brief description of the company’s operations.
– Key Employees – A list of the key executives of the company.
– Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
– Key Competitors – A list of the key competitors of the company.
– Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
– The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
– The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
– Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
– The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
– Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
– Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

Table of content
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
The Translational Genomics Research Institute, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
The Translational Genomics Research Institute, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
The Translational Genomics Research Institute, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
The Translational Genomics Research Institute, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
The Translational Genomics Research Institute, Medical Devices Deals, 2011 to YTD 2017 9
The Translational Genomics Research Institute, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
The Translational Genomics Research Institute, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
TGen Enters into Research Agreement with Baylor Research Institute 11
BIO5 Oro Valley Enters Into Co-Development Agreement With TGen For Alzheimer's Disease 11
Virginia G. Piper Cancer Center And TGen Enter Into Co-Development Agreement With Samuel Oschin Comprehensive Cancer Institute 12
Licensing Agreements 13
Oncoholdings Receives License For ONCO-101 From The Translational Genomics Research Institute 13
Key Employees 15
Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Recent Developments 17
Corporate Communications 17
Aug 25, 2016: Nov. 6 StepNout 5K Aims for Another $1 illion for TGen Cancer Research 17
Jul 27, 2016: Cycle for the Cure raises a record $248,725 for cancer research at TGen 19
Government and Public Interest 21
Jan 23, 2017: Hearst Foundation funds TGen research into cancer-related 'wasting syndrome' 21
Aug 12, 2016: SmartPractice Donates $50,000 to TGen Cancer Research 22
May 09, 2016: TGen and International Team Find New Avenues of Precision Medicine for Treating Cancer 23
May 02, 2016: TGen SU2C Melanoma Dream Team Member Receives $200,000 Sharp Award 26
Apr 01, 2016: TGen and Mayo Clinic scientists issue report in Cell on advances in basal cell carcinoma treatment 28
Mar 21, 2016: Beyond DNA: TGen points the way to Enhanced Precision Medicine with RNA Sequencing 29
Mar 17, 2016: TGen helps track down deadly infection 31
Product News 32
Dec 06, 2016: TGen outliers study reveals benefits of tumor complexity in glioblastoma 32
Jan 17, 2017: TGen identifies compound that could improve drug development against brain cancer 33
Jan 13, 2016: TGen study published targets SGEF protein in treating glioblastoma brain tumors 34
Appendix 35
Methodology 35
About GlobalData 35
Contact Us 35
Disclaimer 35

List of Tables
The Translational Genomics Research Institute, Pharmaceuticals & Healthcare, Key Facts 1
The Translational Genomics Research Institute, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
The Translational Genomics Research Institute, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
The Translational Genomics Research Institute, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
The Translational Genomics Research Institute, Deals By Therapy Area, 2011 to YTD 2017 8
The Translational Genomics Research Institute, Medical Devices Deals, 2011 to YTD 2017 9
The Translational Genomics Research Institute, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
TGen Enters into Research Agreement with Baylor Research Institute 11
BIO5 Oro Valley Enters Into Co-Development Agreement With TGen For Alzheimer's Disease 11
Virginia G. Piper Cancer Center And TGen Enter Into Co-Development Agreement With Samuel Oschin Comprehensive Cancer Institute 12
Oncoholdings Receives License For ONCO-101 From The Translational Genomics Research Institute 13
The Translational Genomics Research Institute, Key Employees 15
The Translational Genomics Research Institute, Other Locations 16
The Translational Genomics Research Institute, Subsidiaries 16

List of Figures
The Translational Genomics Research Institute, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1
The Translational Genomics Research Institute, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1
The Translational Genomics Research Institute, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 1
The Translational Genomics Research Institute, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
The Translational Genomics Research Institute, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6
The Translational Genomics Research Institute, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
The Translational Genomics Research Institute, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
The Translational Genomics Research Institute, Medical Devices Deals, 2011 to YTD 2017 9

News

  • Understanding the Need For Travel Vaccination
  • If you are getting ready for a particular trip that can see you away from your house for about a month or so, then it is necessary for you to take the help of travel vaccinations. Not ...
  • The Work Of The Ophthalmology Specialist
  • When we consider ophthalmology as a branch of science, it is actually about the treatment as well as getting to diagnose the different kinds of diseases and the disorder that is to ...
  • The Process Of Dental Implants And The Subsequent Recovery
  • In the United States of America, the fear of going to a dentist happens to rank number one on the list of children as well as adults. Most of the people are actually concerned when ...
  • The medication that can help the rural population
  • It is not always that you get to see world class hospitals in the rural areas, be it America or any other country. Hence, it is important that people actually take the help of tele-medication, ...
  • The Future of Telemedicine & Its Use
  • When talking about telemedicine, you do get to realize that it is the healthcare of the future. Most of the people do not realize the implications, and for more so the time, telemedicine ...

Get Updates

Share This Post

Recent Posts

© 2020 RnR Company Profiles. All rights reserved.